カテゴリ： 世界, 医療/バイオ, Market Monitor Global

モノクローナル抗体開発サービスのグローバル市場展望 2023年-2029年：小規模、中規模、大規模

■ 英語タイトル：Monoclonal Antibody Development Services Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12401）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12401
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療
■ ページ数：105
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[モノクローナル抗体開発サービスのグローバル市場展望 2023年-2029年：小規模、中規模、大規模]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のモノクローナル抗体開発サービス市場規模と予測を収録しています。・世界のモノクローナル抗体開発サービス市場：売上、2018年-2023年、2024年-2029年
・世界のモノクローナル抗体開発サービス市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のモノクローナル抗体開発サービス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「小規模」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

モノクローナル抗体開発サービスのグローバル主要企業は、Eurogentec、 ProSci、 Syd Labs、 Promab、 Antibodies Inc、 Bhat Biotech、 Synaptic Systems、 Covalab、 CePower、 Lampire Biological Laboratories、 Leinco Technologies、 Medimabs、 Davids Bioengineering、 Scantibodies、 Abwiz Bio、 Thermo Fisher Scientificなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、モノクローナル抗体開発サービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のモノクローナル抗体開発サービス市場：タイプ別、2018年-2023年、2024年-2029年
世界のモノクローナル抗体開発サービス市場：タイプ別市場シェア、2022年
・小規模、中規模、大規模

世界のモノクローナル抗体開発サービス市場：用途別、2018年-2023年、2024年-2029年
世界のモノクローナル抗体開発サービス市場：用途別市場シェア、2022年
・バイオ医薬品、医療診断、農業、医療、環境モニタリング、その他

世界のモノクローナル抗体開発サービス市場：地域・国別、2018年-2023年、2024年-2029年
世界のモノクローナル抗体開発サービス市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるモノクローナル抗体開発サービスのグローバル売上、2018年-2023年
・主要企業におけるモノクローナル抗体開発サービスのグローバル売上シェア、2022年
・主要企業におけるモノクローナル抗体開発サービスのグローバル販売量、2018年-2023年
・主要企業におけるモノクローナル抗体開発サービスのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Eurogentec、 ProSci、 Syd Labs、 Promab、 Antibodies Inc、 Bhat Biotech、 Synaptic Systems、 Covalab、 CePower、 Lampire Biological Laboratories、 Leinco Technologies、 Medimabs、 Davids Bioengineering、 Scantibodies、 Abwiz Bio、 Thermo Fisher Scientific

*************************************************************

・調査・分析レポートの概要
モノクローナル抗体開発サービス市場の定義
市場セグメント
世界のモノクローナル抗体開発サービス市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のモノクローナル抗体開発サービス市場規模
世界のモノクローナル抗体開発サービス市場規模：2022年 VS 2029年
世界のモノクローナル抗体開発サービス市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのモノクローナル抗体開発サービスの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のモノクローナル抗体開発サービス製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：小規模、中規模、大規模
モノクローナル抗体開発サービスのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：バイオ医薬品、医療診断、農業、医療、環境モニタリング、その他
モノクローナル抗体開発サービスの用途別グローバル売上・予測

・地域別市場分析
地域別モノクローナル抗体開発サービス市場規模 2022年と2029年
地域別モノクローナル抗体開発サービス売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Eurogentec、 ProSci、 Syd Labs、 Promab、 Antibodies Inc、 Bhat Biotech、 Synaptic Systems、 Covalab、 CePower、 Lampire Biological Laboratories、 Leinco Technologies、 Medimabs、 Davids Bioengineering、 Scantibodies、 Abwiz Bio、 Thermo Fisher Scientific
...

This research report provides a comprehensive analysis of the Monoclonal Antibody Development Services market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Monoclonal Antibody Development Services market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Monoclonal Antibody Development Services, challenges faced by the industry, and potential opportunities for market players.
The global Monoclonal Antibody Development Services market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Monoclonal Antibody Development Services market presents opportunities for various stakeholders, including Biopharmaceuticals, Medical Diagnosis. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Monoclonal Antibody Development Services market. Additionally, the growing consumer demand present avenues for market expansion.
The global Monoclonal Antibody Development Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Monoclonal Antibody Development Services market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Monoclonal Antibody Development Services market.
Market Overview: The report provides a comprehensive overview of the Monoclonal Antibody Development Services market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Small-scale, Medium-sclae), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Monoclonal Antibody Development Services market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Monoclonal Antibody Development Services market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Monoclonal Antibody Development Services market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Monoclonal Antibody Development Services market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Monoclonal Antibody Development Services market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Monoclonal Antibody Development Services market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Monoclonal Antibody Development Services, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Monoclonal Antibody Development Services market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Monoclonal Antibody Development Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Small-scale
Medium-sclae
Large-scale
Market segment by Application
Biopharmaceuticals
Medical Diagnosis
Agricultural
Medical Treatment
Environmental monitoring
Others
Global Monoclonal Antibody Development Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Eurogentec
ProSci
Syd Labs
Promab
Antibodies Inc
Bhat Biotech
Synaptic Systems
Covalab
CePower
Lampire Biological Laboratories
Leinco Technologies
Medimabs
Davids Bioengineering
Scantibodies
Abwiz Bio
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Monoclonal Antibody Development Services, market overview.
Chapter 2: Global Monoclonal Antibody Development Services market size in revenue.
Chapter 3: Detailed analysis of Monoclonal Antibody Development Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Monoclonal Antibody Development Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Monoclonal Antibody Development Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Monoclonal Antibody Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Monoclonal Antibody Development Services Overall Market Size
2.1 Global Monoclonal Antibody Development Services Market Size: 2022 VS 2029
2.2 Global Monoclonal Antibody Development Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Monoclonal Antibody Development Services Players in Global Market
3.2 Top Global Monoclonal Antibody Development Services Companies Ranked by Revenue
3.3 Global Monoclonal Antibody Development Services Revenue by Companies
3.4 Top 3 and Top 5 Monoclonal Antibody Development Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Monoclonal Antibody Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Monoclonal Antibody Development Services Players in Global Market
3.6.1 List of Global Tier 1 Monoclonal Antibody Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Monoclonal Antibody Development Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Monoclonal Antibody Development Services Market Size Markets, 2022 & 2029
4.1.2 Small-scale
4.1.3 Medium-sclae
4.1.4 Large-scale
4.2 By Type – Global Monoclonal Antibody Development Services Revenue & Forecasts
4.2.1 By Type – Global Monoclonal Antibody Development Services Revenue, 2018-2023
4.2.2 By Type – Global Monoclonal Antibody Development Services Revenue, 2024-2029
4.2.3 By Type – Global Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Monoclonal Antibody Development Services Market Size, 2022 & 2029
5.1.2 Biopharmaceuticals
5.1.3 Medical Diagnosis
5.1.4 Agricultural
5.1.5 Medical Treatment
5.1.6 Environmental monitoring
5.1.7 Others
5.2 By Application – Global Monoclonal Antibody Development Services Revenue & Forecasts
5.2.1 By Application – Global Monoclonal Antibody Development Services Revenue, 2018-2023
5.2.2 By Application – Global Monoclonal Antibody Development Services Revenue, 2024-2029
5.2.3 By Application – Global Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Monoclonal Antibody Development Services Market Size, 2022 & 2029
6.2 By Region – Global Monoclonal Antibody Development Services Revenue & Forecasts
6.2.1 By Region – Global Monoclonal Antibody Development Services Revenue, 2018-2023
6.2.2 By Region – Global Monoclonal Antibody Development Services Revenue, 2024-2029
6.2.3 By Region – Global Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Monoclonal Antibody Development Services Revenue, 2018-2029
6.3.2 US Monoclonal Antibody Development Services Market Size, 2018-2029
6.3.3 Canada Monoclonal Antibody Development Services Market Size, 2018-2029
6.3.4 Mexico Monoclonal Antibody Development Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Monoclonal Antibody Development Services Revenue, 2018-2029
6.4.2 Germany Monoclonal Antibody Development Services Market Size, 2018-2029
6.4.3 France Monoclonal Antibody Development Services Market Size, 2018-2029
6.4.4 U.K. Monoclonal Antibody Development Services Market Size, 2018-2029
6.4.5 Italy Monoclonal Antibody Development Services Market Size, 2018-2029
6.4.6 Russia Monoclonal Antibody Development Services Market Size, 2018-2029
6.4.7 Nordic Countries Monoclonal Antibody Development Services Market Size, 2018-2029
6.4.8 Benelux Monoclonal Antibody Development Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Monoclonal Antibody Development Services Revenue, 2018-2029
6.5.2 China Monoclonal Antibody Development Services Market Size, 2018-2029
6.5.3 Japan Monoclonal Antibody Development Services Market Size, 2018-2029
6.5.4 South Korea Monoclonal Antibody Development Services Market Size, 2018-2029
6.5.5 Southeast Asia Monoclonal Antibody Development Services Market Size, 2018-2029
6.5.6 India Monoclonal Antibody Development Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Monoclonal Antibody Development Services Revenue, 2018-2029
6.6.2 Brazil Monoclonal Antibody Development Services Market Size, 2018-2029
6.6.3 Argentina Monoclonal Antibody Development Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Monoclonal Antibody Development Services Revenue, 2018-2029
6.7.2 Turkey Monoclonal Antibody Development Services Market Size, 2018-2029
6.7.3 Israel Monoclonal Antibody Development Services Market Size, 2018-2029
6.7.4 Saudi Arabia Monoclonal Antibody Development Services Market Size, 2018-2029
6.7.5 UAE Monoclonal Antibody Development Services Market Size, 2018-2029
7 Monoclonal Antibody Development Services Companies Profiles
7.1 Eurogentec
7.1.1 Eurogentec Company Summary
7.1.2 Eurogentec Business Overview
7.1.3 Eurogentec Monoclonal Antibody Development Services Major Product Offerings
7.1.4 Eurogentec Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.1.5 Eurogentec Key News & Latest Developments
7.2 ProSci
7.2.1 ProSci Company Summary
7.2.2 ProSci Business Overview
7.2.3 ProSci Monoclonal Antibody Development Services Major Product Offerings
7.2.4 ProSci Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.2.5 ProSci Key News & Latest Developments
7.3 Syd Labs
7.3.1 Syd Labs Company Summary
7.3.2 Syd Labs Business Overview
7.3.3 Syd Labs Monoclonal Antibody Development Services Major Product Offerings
7.3.4 Syd Labs Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.3.5 Syd Labs Key News & Latest Developments
7.4 Promab
7.4.1 Promab Company Summary
7.4.2 Promab Business Overview
7.4.3 Promab Monoclonal Antibody Development Services Major Product Offerings
7.4.4 Promab Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.4.5 Promab Key News & Latest Developments
7.5 Antibodies Inc
7.5.1 Antibodies Inc Company Summary
7.5.2 Antibodies Inc Business Overview
7.5.3 Antibodies Inc Monoclonal Antibody Development Services Major Product Offerings
7.5.4 Antibodies Inc Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.5.5 Antibodies Inc Key News & Latest Developments
7.6 Bhat Biotech
7.6.1 Bhat Biotech Company Summary
7.6.2 Bhat Biotech Business Overview
7.6.3 Bhat Biotech Monoclonal Antibody Development Services Major Product Offerings
7.6.4 Bhat Biotech Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.6.5 Bhat Biotech Key News & Latest Developments
7.7 Synaptic Systems
7.7.1 Synaptic Systems Company Summary
7.7.2 Synaptic Systems Business Overview
7.7.3 Synaptic Systems Monoclonal Antibody Development Services Major Product Offerings
7.7.4 Synaptic Systems Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.7.5 Synaptic Systems Key News & Latest Developments
7.8 Covalab
7.8.1 Covalab Company Summary
7.8.2 Covalab Business Overview
7.8.3 Covalab Monoclonal Antibody Development Services Major Product Offerings
7.8.4 Covalab Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.8.5 Covalab Key News & Latest Developments
7.9 CePower
7.9.1 CePower Company Summary
7.9.2 CePower Business Overview
7.9.3 CePower Monoclonal Antibody Development Services Major Product Offerings
7.9.4 CePower Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.9.5 CePower Key News & Latest Developments
7.10 Lampire Biological Laboratories
7.10.1 Lampire Biological Laboratories Company Summary
7.10.2 Lampire Biological Laboratories Business Overview
7.10.3 Lampire Biological Laboratories Monoclonal Antibody Development Services Major Product Offerings
7.10.4 Lampire Biological Laboratories Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.10.5 Lampire Biological Laboratories Key News & Latest Developments
7.11 Leinco Technologies
7.11.1 Leinco Technologies Company Summary
7.11.2 Leinco Technologies Business Overview
7.11.3 Leinco Technologies Monoclonal Antibody Development Services Major Product Offerings
7.11.4 Leinco Technologies Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.11.5 Leinco Technologies Key News & Latest Developments
7.12 Medimabs
7.12.1 Medimabs Company Summary
7.12.2 Medimabs Business Overview
7.12.3 Medimabs Monoclonal Antibody Development Services Major Product Offerings
7.12.4 Medimabs Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.12.5 Medimabs Key News & Latest Developments
7.13 Davids Bioengineering
7.13.1 Davids Bioengineering Company Summary
7.13.2 Davids Bioengineering Business Overview
7.13.3 Davids Bioengineering Monoclonal Antibody Development Services Major Product Offerings
7.13.4 Davids Bioengineering Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.13.5 Davids Bioengineering Key News & Latest Developments
7.14 Scantibodies
7.14.1 Scantibodies Company Summary
7.14.2 Scantibodies Business Overview
7.14.3 Scantibodies Monoclonal Antibody Development Services Major Product Offerings
7.14.4 Scantibodies Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.14.5 Scantibodies Key News & Latest Developments
7.15 Abwiz Bio
7.15.1 Abwiz Bio Company Summary
7.15.2 Abwiz Bio Business Overview
7.15.3 Abwiz Bio Monoclonal Antibody Development Services Major Product Offerings
7.15.4 Abwiz Bio Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.15.5 Abwiz Bio Key News & Latest Developments
7.16 Thermo Fisher Scientific
7.16.1 Thermo Fisher Scientific Company Summary
7.16.2 Thermo Fisher Scientific Business Overview
7.16.3 Thermo Fisher Scientific Monoclonal Antibody Development Services Major Product Offerings
7.16.4 Thermo Fisher Scientific Monoclonal Antibody Development Services Revenue in Global Market (2018-2023)
7.16.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Monoclonal Antibody Development Services Market Opportunities & Trends in Global Market
Table 2. Monoclonal Antibody Development Services Market Drivers in Global Market
Table 3. Monoclonal Antibody Development Services Market Restraints in Global Market
Table 4. Key Players of Monoclonal Antibody Development Services in Global Market
Table 5. Top Monoclonal Antibody Development Services Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Monoclonal Antibody Development Services Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Monoclonal Antibody Development Services Revenue Share by Companies, 2018-2023
Table 8. Global Companies Monoclonal Antibody Development Services Product Type
Table 9. List of Global Tier 1 Monoclonal Antibody Development Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Monoclonal Antibody Development Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Monoclonal Antibody Development Services Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Monoclonal Antibody Development Services Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Monoclonal Antibody Development Services Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Monoclonal Antibody Development Services Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Monoclonal Antibody Development Services Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Monoclonal Antibody Development Services Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Monoclonal Antibody Development Services Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Monoclonal Antibody Development Services Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Monoclonal Antibody Development Services Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Monoclonal Antibody Development Services Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Monoclonal Antibody Development Services Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Monoclonal Antibody Development Services Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Monoclonal Antibody Development Services Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Monoclonal Antibody Development Services Revenue, (US$, Mn), 2024-2029
Table 30. Eurogentec Company Summary
Table 31. Eurogentec Monoclonal Antibody Development Services Product Offerings
Table 32. Eurogentec Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 33. Eurogentec Key News & Latest Developments
Table 34. ProSci Company Summary
Table 35. ProSci Monoclonal Antibody Development Services Product Offerings
Table 36. ProSci Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 37. ProSci Key News & Latest Developments
Table 38. Syd Labs Company Summary
Table 39. Syd Labs Monoclonal Antibody Development Services Product Offerings
Table 40. Syd Labs Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 41. Syd Labs Key News & Latest Developments
Table 42. Promab Company Summary
Table 43. Promab Monoclonal Antibody Development Services Product Offerings
Table 44. Promab Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 45. Promab Key News & Latest Developments
Table 46. Antibodies Inc Company Summary
Table 47. Antibodies Inc Monoclonal Antibody Development Services Product Offerings
Table 48. Antibodies Inc Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 49. Antibodies Inc Key News & Latest Developments
Table 50. Bhat Biotech Company Summary
Table 51. Bhat Biotech Monoclonal Antibody Development Services Product Offerings
Table 52. Bhat Biotech Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 53. Bhat Biotech Key News & Latest Developments
Table 54. Synaptic Systems Company Summary
Table 55. Synaptic Systems Monoclonal Antibody Development Services Product Offerings
Table 56. Synaptic Systems Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 57. Synaptic Systems Key News & Latest Developments
Table 58. Covalab Company Summary
Table 59. Covalab Monoclonal Antibody Development Services Product Offerings
Table 60. Covalab Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 61. Covalab Key News & Latest Developments
Table 62. CePower Company Summary
Table 63. CePower Monoclonal Antibody Development Services Product Offerings
Table 64. CePower Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 65. CePower Key News & Latest Developments
Table 66. Lampire Biological Laboratories Company Summary
Table 67. Lampire Biological Laboratories Monoclonal Antibody Development Services Product Offerings
Table 68. Lampire Biological Laboratories Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 69. Lampire Biological Laboratories Key News & Latest Developments
Table 70. Leinco Technologies Company Summary
Table 71. Leinco Technologies Monoclonal Antibody Development Services Product Offerings
Table 72. Leinco Technologies Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 73. Leinco Technologies Key News & Latest Developments
Table 74. Medimabs Company Summary
Table 75. Medimabs Monoclonal Antibody Development Services Product Offerings
Table 76. Medimabs Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 77. Medimabs Key News & Latest Developments
Table 78. Davids Bioengineering Company Summary
Table 79. Davids Bioengineering Monoclonal Antibody Development Services Product Offerings
Table 80. Davids Bioengineering Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 81. Davids Bioengineering Key News & Latest Developments
Table 82. Scantibodies Company Summary
Table 83. Scantibodies Monoclonal Antibody Development Services Product Offerings
Table 84. Scantibodies Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 85. Scantibodies Key News & Latest Developments
Table 86. Abwiz Bio Company Summary
Table 87. Abwiz Bio Monoclonal Antibody Development Services Product Offerings
Table 88. Abwiz Bio Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 89. Abwiz Bio Key News & Latest Developments
Table 90. Thermo Fisher Scientific Company Summary
Table 91. Thermo Fisher Scientific Monoclonal Antibody Development Services Product Offerings
Table 92. Thermo Fisher Scientific Monoclonal Antibody Development Services Revenue (US$, Mn) & (2018-2023)
Table 93. Thermo Fisher Scientific Key News & Latest Developments
List of Figures
Figure 1. Monoclonal Antibody Development Services Segment by Type in 2022
Figure 2. Monoclonal Antibody Development Services Segment by Application in 2022
Figure 3. Global Monoclonal Antibody Development Services Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Monoclonal Antibody Development Services Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Monoclonal Antibody Development Services Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Monoclonal Antibody Development Services Revenue in 2022
Figure 8. By Type - Global Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
Figure 9. By Application - Global Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
Figure 10. By Type - Global Monoclonal Antibody Development Services Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
Figure 12. By Application - Global Monoclonal Antibody Development Services Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
Figure 14. By Region - Global Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
Figure 15. By Country - North America Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
Figure 16. US Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
Figure 20. Germany Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 21. France Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
Figure 28. China Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 32. India Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
Figure 34. Brazil Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Monoclonal Antibody Development Services Revenue Market Share, 2018-2029
Figure 37. Turkey Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Monoclonal Antibody Development Services Revenue, (US$, Mn), 2018-2029
Figure 41. Eurogentec Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. ProSci Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Syd Labs Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Promab Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Antibodies Inc Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bhat Biotech Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Synaptic Systems Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Covalab Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. CePower Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Lampire Biological Laboratories Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Leinco Technologies Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Medimabs Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Davids Bioengineering Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Scantibodies Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Abwiz Bio Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Thermo Fisher Scientific Monoclonal Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ウサギモノクローナル抗体のグローバル市場展望 2023年-2029年：組織再編、非組換え
  • 抗イディオタイプ抗体作製サービスのグローバル市場展望 2023年-2029年：モノクローナル抗イディオタイプ抗体、ポリクローナル抗イディオタイプ抗体
  • CD161抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • 抗CD3抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • ASL抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC12401 )"モノクローナル抗体開発サービスのグローバル市場展望 2023年-2029年：小規模、中規模、大規模" (英文：Monoclonal Antibody Development Services Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。